Uppsala University
Uppsala, 752 37, Sweden
NCT Number: NCT07706816
The goal of this feasibility study is to learn if the randomised controlled trial evaluating the Remote-delivery Balance in Everyday Life (rBEL) programme for adults younger than 55 years who have experienced a myocardial infarction (MI), is feasible.
The objective is to examine the feasibility of the rBEL programme and the associated study procedures before a controlled evaluation of the programme. This is an uncontrolled, single-arm, pre-post treatment designed study.
Participants of the target population will take part of the six session over 13 week programme. Feasibility will be evaluated against predefined feasibility criteria regarding study procedures and programme acceptability.
Trial opening soon.
Get Notified18 year–55 year
All sexes
Interventional
Not applicable
Uppsala, 752 37, Sweden
BACKGROUND Even though there have been major improvements in medical treatments resulting in considerably lower mortality rates, cardiovascular diseases (CVDs) remain the leading cause of death and the main cause of loss of disability-adjusted life-years worldwide. Myocardial infarction (MI) is the most common of the serious CVDs. While the total number of MIs has decreased during the last decades, the proportion of young patients hospitalized with MI has increased.
Cardiac distress (CD) summaries the psychological impacts of a cardiac event and expands on the general "psychological distress" concept (i.e. symptoms of depression and anxiety). Cardiac distress is common after an MI. For young persons, having an MI is particularly stressful and the prevalence of anxiety and depression is more than double compared to that of older patients.
Conventional stress management intervention programs are based on a "reactivity paradigm", with techniques used to reduce, avoid, or change the interpretation of the stressors and/or stress responses associated with distress. An alternative, contrasting strategy is to address recovery processes. To the best of our knowledge, the intervention program Balance in Everyday Life (BEL), based on cognitive behavioural principles, has the best empirical support.
Guidelines for cardiac rehabilitation recommend screening of psychosocial aspects but interventions in this area are very rare in clinical practice.
METHOD Aim The aims are to assess feasibility and acceptability of the iBEL program for post-myocardial infarction survivors aged below 55 years reported ongoing CD, and the study procedures of the later evaluation study.
Research Questions
Design An uncontrolled, single-arm, pre-post treatment design.
Participants Thirty participants of the target population will be included. Exclusion criteria: (i) not being able to read, write or speak Swedish, (ii) being able to use the digital device necessary for participation and (iii) early retirement or disability pension at the time of the MI.
Procedure Participants will be recruited via a register extraction from SWEDEHEART of all persons having an MI before the age of 55 one year before intervention start. Preliminary eligible participants will be sent an invitation letter primarily via a digital post-box with a description of the study and an option to register interest for the study. To qualify as participants with CD, they must state they have at least experienced moderate distress as a consequence of their MI which impairs day-to-day recovery, and they believe psychological support will benefit them. They are then asked to provide written consent.
The Program The program consists of 6 sessions spread out over 13 weeks. Each session includes a video-call meeting online, via the platform Zoom, with a therapist. The therapists are healthcare workers (clinical social workers-LCSW, MSW specialized in psychotherapy, nurses psychiatric/mental health nurse practitioners- PMHNPs, occupational therapists with mental health specialization) with training in clinical conversations or students recruited from the final semesters of the university programs for psychologists or physiotherapists with basic training in clinical conversations. They will be trained in the rBEL program and receive supervision by a senior therapist. Before each data collection time-point, participants will be prompted and, if necessary, reminded to report via SMS and/or e-mail, based on their preference, and thereafter, if needed, via telephone.
In addition to this meeting with the therapist there is psychoeducational material on a website (www.brim55.se) and a printed booklet for exercise notations.
Data analysis The feasibility results will be evaluated against pre-specified progression criteria. The sample size (N=30) is based on a rule-of-thumb for feasibility studies and is judged to be enough for detecting feasibility concerns.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Remote-delivery Balance in Everyday Life (rBEL) program is a 13-week therapist-supported behavioral stress recovery intervention for adults younger than 55 years who have experienced a myocardial infarction and report cardiac distress. The program includes six individual online sessions delivered by a therapist, a printed exercise workbook, and online video materials. The content focuses on recovery behaviors, relaxation training, self-monitoring, use of recovery strategies in daily life and work settings, and management of heart-related worry and anxiety.
Time frame: Six weeks from when the invitation letter was sent out
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.
Green: ≥8% of the invited population starting intervention. Yellow: <8% and ≥6%. Red: <6%.
Time frame: Four weeks from the screening interview
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.
Green: ≥75% of eligible participants consent. Yellow: <75% and ≥60%. Red: <60%.
Time frame: From start of intervention to 12 weeks later.
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.
Green: ≥70% of the participants completing a minimum of 4 sessions with the therapist.
Yellow:<70% and ≥60%. Red: <60%
Time frame: From the end of the intervention to two weeks later.
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.
Green: ≥90% complete data on the CDI, post-treatment. Yellow: <90% and ≥75%. Red: <75%.
Time frame: From intervention start to four weeks after intervention end.
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise.
Green: no inconveniences or adverse events linked to study participation reported.
Yellow: ≤ 2 reports of inconveniences (comparable to max 2 days of increased fatigue, stress or worry).
Red: any adverse event or more than 3 inconveniences reported linked to study participation
Time frame: Rating is done after first intervention session (first week of intervention). A two week submission period is allowed.
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise. The credibility subscale of the Credibility and Expectancy Questionnaire has a max score of 27. A higher score means more credibility.
Green: ≥75% of participants rate the credibility subscale of CEQ ≥ 7. Yellow: ≥75% rate it < 7 and ≥ 5. Red: >25% rate it < 5.
Time frame: From the end of the intervention to two weeks later.
The pre-specified progression criteria are formulated as Green=Go ahead, Yellow=Amend, Red=Revise. The Client Satisfaction Questionnaire 8 items version (CSQ-8) has a max score of 32 where a higher score means more satisfaction.
Green: ≥ 75% of participants score ≥26 on the CSQ-8. Yellow: ≥ 75% rate it ≥24. Red: > 25% rate it <24.
Time frame: Mid intervention (CDI short form): After session 3 (2 week submission period) After intervention: From the end of the intervention to two weeks later.
Cardiac Distress Inventory (CDI)
Time frame: Mid intervention: After session 3 (2 week submission time frame). After intervention: From the end of the intervention to two weeks later.
The Recovery Experience Questionnaire (REQ) has a max score of 80 where a higher score means more recovery.
Time frame: From the end of the intervention to two weeks later.
The HeartQoL instrument has a max score of 42 where a higher score means better quality of life.
Time frame: From the end of the intervention to two weeks later.
The Patient Health Questionnaire, 9 items (PHQ-9) has a max score of 27. A higher score means more depressed.
Time frame: From the end of the intervention to two weeks later.
The instrument General Anxiety Disorder, 7 items version (GAD-7) has a max score of 21. A higher score means more anxiety.
Time frame: From the end of the intervention to two weeks later.
Work Ability Index has a max score of 49 where a higher score means better working ability.
Time frame: From the end of the intervention to two weeks later.
The instrument Treatment Inventory of Costs in Patients with psychiatric disorders, Midi version (TIC-P Midi) counts visits in health care. The more visits the higher the costs. Visits to specialists and hospital stays means higher costs than outpatient visits.
Contact information is provided by the study sponsor or research team.
Uppsala University
Other
Acronym: BRIM-55
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05476991
Angina Pectoris, Angina, Unstable
Paris, France
View Trial DetailsNCT05647577
Ankylosis, Arthritis
Hellerup, Denmark
View Trial DetailsNCT03466255
Acute Coronary Syndrome, Arterial Occlusive Diseases
Kingston, Ontario, Canada
View Trial DetailsNCT03303703
Cardiac Disease, Cardiovascular Diseases
Cleveland, Ohio, United States
View Trial Details